bpc 157/heart attack The Stable Gastric Pentadecapeptide 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity BPC-157 therapy in the cardiovascular

A 2021 peer-reviewed review of NNMT in obesity and type 2 diabetes states explicitly that 'clinical trials targeting NNMT have not been reported' meaning every quantitative efficacy figure available for this compound comes from mice, and there is currently zero published human efficacy data

BPC-157 falls into the category of research chemicals available for in vitro and animal laboratory use, a legal classification that prohibits sale with claims of human health benefits or as a finished dosage product for human consumption

Moreover, many rely on subjective symptom scales rather than objective physiological or biochemical endpoints, which may overestimate treatment effects

As tolerance to Phentermine continues to build over weeks and months, these side effects gradually subside

The improved blood flow stimulated by BPC-157 can also help: Decrease blood pressure